Sign in

CIK 0000874015

  • Large accelerated filer

IONIS PHARMACEUTICALS INC

Sign in to watch
Ticker
IONS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
330336973
Phone
+1 760-931-9200
Business address
2855 GAZELLE COURT, CARLSBAD, CA, 92010
Former names
ISIS PHARMACEUTICALS INC
Open-market buys, last 90 days
$148,200
in 1 filing
Open-market sales, last 90 days
$61,389
in 2 filings

Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-10-01 WENDER JOSEPH H Director Sale 10b5-1 −16,800 $65.50 $1.1M 92,035
2025-10-01 Swayze Eric EVP Research Option exercise 10b5-1 +14,142 $53.77 $760K 51,444
2025-10-01 Swayze Eric EVP Research Sale 10b5-1 −14,142 $66.09 $935K 37,302
2025-10-01 Swayze Eric EVP Research Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −14,142 12,972
2025-09-30 O'NEIL PATRICK R. EVP CLO & General Counsel Option exercise 10b5-1 +14,827 $56.78 $842K 71,957
2025-09-30 O'NEIL PATRICK R. EVP CLO & General Counsel Sale 10b5-1 −14,827 $64.68 $959K 57,130
2025-09-30 O'NEIL PATRICK R. EVP CLO & General Counsel Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −14,827 30,203
2025-09-30 Geary Richard S EVP, Chief Development Officer Option exercise 10b5-1 +57,900 $53.77 $3.1M 137,557
2025-09-30 Geary Richard S EVP, Chief Development Officer Sale 10b5-1 −57,900 $65.24 $3.8M 79,657
2025-09-30 Geary Richard S EVP, Chief Development Officer Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −57,900 0
2025-09-30 HOUGEN ELIZABETH L EVP, Finance & CFO Option exercise 10b5-1 +49,800 $53.77 $2.7M 160,300
2025-09-30 HOUGEN ELIZABETH L EVP, Finance & CFO Sale 10b5-1 −49,800 $65.26 $3.2M 110,500
2025-09-30 HOUGEN ELIZABETH L EVP, Finance & CFO Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −49,800 0
2025-09-29 O'NEIL PATRICK R. EVP CLO & General Counsel Option exercise 10b5-1 +10,473 $56.78 $595K 67,603
2025-09-29 O'NEIL PATRICK R. EVP CLO & General Counsel Sale 10b5-1 −10,473 $64.54 $676K 57,130
2025-09-29 O'NEIL PATRICK R. EVP CLO & General Counsel Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −10,473 45,030
2025-09-12 O'NEIL PATRICK R. EVP CLO & General Counsel Option exercise 10b5-1 +1,700 $56.78 $97K 58,830
2025-09-12 O'NEIL PATRICK R. EVP CLO & General Counsel Sale 10b5-1 −1,700 $64.58 $110K 57,130
2025-09-12 O'NEIL PATRICK R. EVP CLO & General Counsel Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −1,700 55,503
2025-09-09 Baroldi Joseph EVP, Chief Business Officer Option exercise 10b5-1 +11,950 $31.80 $380K 43,876

Page 23 of 34 · 668 trades